Testosterone therapy increases VTE risk in the short-term

Men on testosterone therapy are exposed to a greater risk of venous thromboembolism (VTE)  during the first few months of treatment, warn experts who say that until now, a failure to investigate the timing and duration of use on VTE risk has masked the association. The risk increases rapidly over the first three months of ...

Already a member?

Login to keep reading.

© 2021 the limbic